Why use cannabis in old age?
Typical reasons include chronic pain (e.g., neuropathic/osteoarthritis), sleep problems , loss of appetite , or spasticity. Meta-analyses and guidelines show that the average benefit is rather small , but can be clinically relevant for selected patients—especially when standard options are insufficiently effective or poorly tolerated. The BMJ panel (2021) therefore weakly recommends a trial of non-inhaled cannabis-based medicines in addition to standard therapy.
Recent reviews (2023–2025) emphasize that neuropathic pain is most likely to benefit; for other forms of pain, the evidence is limited/heterogeneous.
Sleep : Improvements are possible, but on average small and unreliable – especially in older patients, often dependent on comorbidities (pain, anxiety).
Special risks for seniors
Older people are more likely to have multiple health conditions and be on multiple medications – they react more strongly to THC (sedation, confusion), which can increase the risk of falls . Observations and studies show an increased risk of falls and gait disturbances among older cannabis users; caution is advised, especially when starting or increasing use.
Cardiovascular : Regular use is associated with a higher risk of heart attack/stroke/heart failure ; the risk increases with frequency of use. Exercise particular caution in patients with pre-existing cardiac conditions and critically evaluate inhalants.
Cognition/Neuropsychiatric : Older adults are more susceptible to cognitive impairment, delirium, and anxiety , especially with high THC doses. Data also show an increased risk of cannabis use disorder (CUD ) – therefore screening and education are important.
Interactions (very important!)
Cannabinoids affect CYP enzymes (CYP2C19, CYP3A4, etc.). Documented interactions include:
-
Clobazam (increases active metabolites)
-
Warfarin / DOACs (increased risk of bleeding → monitor INR/signs of bleeding )
-
Tacrolimus (level rise)
-
various antiepileptic drugs
Plan therapies → Include interaction checks and laboratory tests.
Application & dosage (“Start low, go slow”)
basic principles
-
Start with a low dose , increase slowly ; test only at night (sedation).
-
Define a treatment goal (pain ↓ x %, sleep +xh) and set a time window (e.g. 4–8 weeks); continue only if beneficial.
-
Avoid smoking ; prefer non-inhaled forms, consider vaporization as a less harmful inhalation alternative (see below).
Example schemes (orientation, always medical!)
-
THC (non-inhalant) : 1–2,5 mg in the evening; increase by 1–2,5 mg every 3–7 days until effect/side effects are observed.
-
CBD (non-inhalant) : 5–10 mg 1–2 times/day; increase gradually (especially for anxiety/sleep, be aware of interactions).
-
Combination : CBD during the day, low THC in the evening (e.g. 1–2,5 mg), titrate carefully.
-
Inhalation (vaporizer): 1–2 moves, Wait 15 minutes, repeat only if necessary; Temperature moderate (approx. 180–195 °C) for a gentle start.
Practical geriatric dosage recommendations (toolkit) emphasize the slow, step-by-step approach.
Note: Edibles have a delayed effect (30–90 min., peak later) and a longer duration of action; overdoses are more common. Not suitable for first-time users.
Applications: What is suitable for older people?
-
Oral drops/sprays/capsules : slower onset of action, but longer lasting; preferred for basic pain and sleep. (BMJ recommendation explicitly refers to non-inhaled forms.)
-
Vaporizing : no combustion , lower emissions compared to smoking; faster onset of action – useful for breakthrough pain/nausea. However, be aware of cardiovascular/pulmonary risks. Smoking should be avoided.
Safety checklist for practice
-
Check for pre-existing conditions : cardiac, psychiatric, cognitive, fall/gait instability.
-
Medication review : Anticoagulants, antiepileptics, immunosuppressants → Interaction monitoring.
-
Define the treatment goal and discontinuation criteria (e.g., < 30% pain reduction after 8 weeks → discontinue).
-
Fall prevention : Start sitting, test at night, use aids, change positions slowly.
-
Fitness to drive : Do not drive under the influence/during dose escalation.
-
Follow-up : initially weekly/bi-weekly, later every 1–3 months.
Legal Quick Overview (Germany, 2025)
-
Medical use : Cannabis (flowers, extracts, THC-based medications) is prescribable; since 2017, it is generally reimbursable (with certain conditions). The Cannabis Act/Medical Cannabis Act 2024/25 have restructured the legal framework (removing cannabis from the Narcotics Act; separate rules for medicine vs. recreational use/cultivation). Details/FAQs are available from the Federal Ministry of Health.
-
Important : This article does not replace individual medical advice.
Key messages in 30 seconds
-
Areas of application with sometimes moderate evidence: chronic pain (especially neuropathic), sleep disorders – benefit usually small to moderate , varies considerably from person to person. A BMJ guideline weakly recommends a time-limited trial of non-inhaled preparations in addition to standard therapy.
-
Older people are more vulnerable : more side effects (dizziness, confusion), risk of falls , cardiovascular events – therefore dose particularly carefully and monitor closely.
-
Avoid smoking . Vaporizing can reduce emissions/pollutants compared to smoking (harm reduction), but should be evaluated with caution in the case of cardiovascular/pulmonary risks.
-
Interactions : especially CBD/THC with CYP substrates (e.g., clobazam, warfarin, tacrolimus, certain antiepileptic drugs) – plan for monitoring (e.g., INR).
-
Germany (2025): Medical cannabis remains prescribable (flowers, extracts, THC-based medicines) – CanG/MedCanG have reformed the environment; recreational CanG regulates possession/cultivation, not therapy.
Frequently Asked Questions (FAQ)
Does cannabis reliably help with pain in old age?
For some – yes, especially for neuropathic painOn average, effects small; therefore as limited additional attempt to standard therapy.
Is vaping “healthy”?
Evaporation can increase emissions/pollutants compared to Smoking reduce (Harm Reduction), but no health guarantee, especially in cases of heart/lung diseases.
How do I start dosing?
"Start low, go slow– e.g., THC 1–2,5 mg in the evening, increase slowly; CBD 5–10 mg 1–2 times a day. Inhalation: 1–2 puffs, wait 15 minutes. Always supervise under medical supervision.
Which interactions are critical?
Clobazam, warfarin, tacrolimus, various antiepileptics (CYP-dependent). Laboratories/Mirrors monitor.
Does cannabis increase my risk of falls?
Can occur – especially at the start of therapy/when increasing the dose (dizziness, drop in blood pressure, sedation). Observe fall prevention measures.
Concluding Remarks
For seniors, cannabis can be an option – but not a solution for everyone. The key is individualized, cautious use with clear goals, close monitoring , and an honest assessment of the benefits and risks . Avoiding smoking , checking for drug interactions , and taking fall prevention seriously – then a time-limited trial of therapy can be beneficial.
